Roberto Furlan graduated in medicine at the University of Milano in 1991. In 1992 he was visiting scientist in the Department of Neurology of the University of Chicago, working on HTLV-I. In 1993 he was in the Clinical Laboratories of the Sao Rafael Hospital in Salvador-Bahia, in Brazil. From 1994 to 1995 he worked as a post-doc in the Department of Molecular Genetics and Biochemistry, University of Pittsburgh, on HSV-1-mediated gene therapy of the central nervous system. Using HSV-1-derived vectors he performed gene therapy studies in multiple sclerosis models and in 2001 he obtained his PhD at the Open University of London working in the Neuroimmunology Unit of IRCCS Ospedale San Raffaele. where he became also tenure-track research assistant, then senior scientist, and completed in 2007 the residency in neurology. Since 2004, non-tenured professor at Università Vita-Salute San Raffaele. Since 2009, Group leader and then Head of Unit of the Clinical neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS Ospedale San Raffaele. Since 2011 Secretary treasurer of the International Society of NeuroImmunology. Since 2013 Academic Editor for Plos One. Roberto Furlan was awarded the De Visart" Award for Neurological Research, in 1995; the Teva and Marion Hoechst Award on Multiple Sclerosis from the European Charcot Foundation, in 1999; and the Rita Levi Montalcini Award from Italian Multiple Sclerosis Asssociation in 2009.